Management and Executive

Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

General Application

Ataraxis AI is an AI precision medicine company focused on transforming cancer treatment through innovative AI-native tools. They seek passionate individuals at any career stage who are driven to make an impact and deliver results in the field of oncology.

Sign up with Google

Sign in with Google